Sign Up Today and Learn More About Kallyope Stock
Invest in or calculate the value of your shares in Kallyope or other pre-IPO companies through EquityZen's platform.
Kallyope Stock (KALL)
Kallyope is a healthcare company focusing on biotechnology business.
About Kallyope Stock
Founded
2015
Headquarters
New York, NY, US
Total Funding
110M
Industries
Software, Artificial Intelligence, Data and Analytics
Kallyope Press Mentions
Stay in the know about the latest news on Kallyope
NK3 receptor antagonists described in Kallyope patent
bioworld • Nov 20, 2024
Kallyope divulges new tachykinin NK3 receptor antagonists for migraine
bioworld • Nov 15, 2024
NYC's Bold Move: Life Sciences Take Center Stage
fiercebiotech • May 20, 2024
Biotech VCs See Room for More Growth in Obesity Drug Market
wsj • May 20, 2024
Gpr119 and gpr40 agonist combination therapies for gut-brain axis disorders
patents • Apr 15, 2024
Investors in Kallyope
Discover investors in Kallyope stock and explore their portfolio companies
Kallyope Management
Leadership team at Kallyope
CEO
Nancy Thornberry
Founder
Tom Maniatis
Join now and verify your accreditation status to gain access to:
- Kallyope current valuation
- Kallyope stock price
- Available deals in Kallyope and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Kallyope stock?
Accredited investors can buy pre-IPO stock in companies like Kallyope through EquityZen funds. These investments are made available by existing Kallyope shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Kallyope stock?
Shareholders can sell their Kallyope stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
